Receptor-Binding and Oncogenic Properties of Polyoma Viruses Isolated from Feral Mice

Laboratory strains of the mouse polyoma virus differ markedly in their abilities to replicate and induce tumors in newborn mice. Major determinants of pathogenicity lie in the sialic binding pocket of the major capsid protein Vp1 and dictate receptor-binding properties of the virus. Substitutions at two sites in Vp1 define three prototype strains, which vary greatly in pathogenicity. These strains replicate in a limited fashion and induce few or no tumors, cause a disseminated infection leading to the development of multiple solid tumors, or replicate and spread acutely causing early death. This investigation was undertaken to determine the Vp1 type(s) of new virus isolates from naturally infected mice. Compared with laboratory strains, truly wild-type viruses are constrained with respect to their selectivity and avidity of binding to cell receptors. Fifteen of 15 new isolates carried the Vp1 type identical to that of highly tumorigenic laboratory strains. Upon injection into newborn laboratory mice, the new isolates induced a broad spectrum of tumors, including ones of epithelial as well as mesenchymal origin. Though invariant in their Vp1 coding sequences, these isolates showed considerable variation in their regulatory sequences. The common Vp1 type has two essential features: 1) failure to recognize “pseudoreceptors” with branched chain sialic acids binding to which would attenuate virus spread, and 2) maintenance of a hydrophobic contact with true receptors bearing a single sialic acid, which retards virus spread and avoids acute and potentially lethal infection of the host. Conservation of these receptor-binding properties under natural selection preserves the oncogenic potential of the virus. These findings emphasize the importance of immune protection of neonates under conditions of natural transmission.

[1]  H. Ploegh,et al.  Murine Polyomavirus Requires the Endoplasmic Reticulum Protein Derlin-2 To Initiate Infection , 2006, Journal of Virology.

[2]  J. Gilbert,et al.  Downregulation of Protein Disulfide Isomerase Inhibits Infection by the Mouse Polyomavirus , 2006, Journal of Virology.

[3]  Xiaoyu Wang,et al.  Independent Contributions of Polyomavirus Middle T and Small T to the Regulation of Early and Late Gene Expression and DNA Replication , 2006, Journal of Virology.

[4]  M. Baryshev,et al.  ERp29 triggers a conformational change in polyomavirus to stimulate membrane binding. , 2005, Molecular cell.

[5]  Thilo Stehle,et al.  Gangliosides are receptors for murine polyoma virus and SV40 , 2003, The EMBO journal.

[6]  G. Magnusson,et al.  Cellular Mobile Genetic Elements in the Regulatory Region of the Pneumotropic Mouse Polyomavirus Genome: Structure and Function in Viral Gene Expression and DNA Replication , 2003, Journal of Virology.

[7]  G. Magnusson,et al.  Kilham Polyomavirus: Activation of Gene Expression and DNA Replication in Mouse Fibroblast Cells by an Enhancer Substitution , 2001, Journal of Virology.

[8]  T. Benjamin,et al.  Polyoma virus: old findings and new challenges. , 2001, Virology.

[9]  S. Harrison,et al.  Discrimination between Sialic Acid-Containing Receptors and Pseudoreceptors Regulates Polyomavirus Spread in the Mouse , 2000, Journal of Virology.

[10]  S. Harrison,et al.  High‐resolution structure of a polyomavirus VP1‐oligosaccharide complex: implications for assembly and receptor binding , 1997, The EMBO journal.

[11]  R. Bronson,et al.  Tumor induction by a transformation-defective polyoma virus mutant blocked in signaling through Shc. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Harrison,et al.  Crystal structures of murine polyomavirus in complex with straight-chain and branched-chain sialyloligosaccharide receptor fragments. , 1996, Structure.

[13]  S. Harrison,et al.  Genetic and structural analysis of a virulence determinant in polyomavirus VP1 , 1995, Journal of virology.

[14]  M. Fluck,et al.  Enhancer-mediated role for polyomavirus middle T/small T in DNA replication , 1995, Journal of virology.

[15]  D. Blangy,et al.  Transcriptional activity in 3T3, F9, and PCC4 embryonal carcinoma cells: a systematic deletion and linker-scanning study of the polyomavirus enhancer. , 1994, Virology.

[16]  Thilo Stehle,et al.  Structure of murine polyomavirus complexed with an oligosaccharide receptor fragment , 1994, Nature.

[17]  L. Couture,et al.  Polyomavirus enhancer requirements for expression in embryonal carcinoma cells. , 1993, The International journal of developmental biology.

[18]  R. Bronson,et al.  Separation of immortalization from tumor induction with polyoma large T mutants that fail to bind the retinoblastoma gene product. , 1992, Oncogene.

[19]  A. Amalfitano,et al.  Different roles for two enhancer domains in the organ- and age-specific pattern of polyomavirus replication in the mouse. , 1992, Molecular and cellular biology.

[20]  L. Villarreal,et al.  Enhancer dependence of polyomavirus persistence in mouse kidneys , 1992, Journal of virology.

[21]  T. Benjamin,et al.  Polyomavirus tumor induction in mice: effects of polymorphisms of VP1 and large T antigen , 1991, Journal of virology.

[22]  R. Garcea,et al.  A single-amino-acid substitution in polyomavirus VP1 correlates with plaque size and hemagglutination behavior , 1991, Journal of virology.

[23]  T. Dubensky,et al.  Polyomavirus replication in mice: influences of VP1 type and route of inoculation , 1991, Journal of virology.

[24]  L. Villarreal,et al.  Genetic analysis of the enhancer requirements for polyomavirus DNA replication in mice , 1990, Journal of virology.

[25]  T. Benjamin,et al.  Duplication of noncoding sequences in polyomavirus specifically augments the development of thymic tumors in mice , 1988, Journal of virology.

[26]  G. Carmichael,et al.  Polyomavirus tumor induction in mice: influences of viral coding and noncoding sequences on tumor profiles , 1987, Journal of virology.

[27]  M. DePamphilis,et al.  The origin of bidirectional DNA replication in polyoma virus. , 1987, The EMBO journal.

[28]  D. Talmage,et al.  Variations in polyoma virus genotype in relation to tumor induction in mice. Characterization of wild type strains with widely differing tumor profiles. , 1987, The American journal of pathology.

[29]  M. Israel,et al.  A determinant of polyomavirus virulence enhances virus growth in cells of renal origin , 1985, Journal of virology.

[30]  M. Yaniv,et al.  Polyoma DNA sequences involved in control of viral gene expression in murine embryonal carcinoma cells , 1981, Nature.

[31]  E. Linney,et al.  Mutation near the polyoma DNA replication origin permits productive infection of F9 embryonal carcinoma cells , 1981, Cell.

[32]  J. Paulson,et al.  Polyoma virus recognizes specific sialyligosaccharide receptors on host cells. , 1981, Virology.

[33]  A. Levine,et al.  Isolation and characterization of polyoma host range mutants that replicate in nullipotential embryonal carcinoma cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Paulson,et al.  Polyoma virus adsorbs to specific sialyloligosaccharide receptors on erythrocytes. , 1980, Virology.

[35]  B. Henderson,et al.  Brief Communication: Spontaneous Tumors and C-Type Virus in PolyomaInfected Aging Wild House Mice , 1974 .

[36]  S. E. Stewart The Polyoma Virus , 1960 .

[37]  R. Huebner,et al.  STUDIES OF MOUSE POLYOMA VIRUS INFECTION : I. PROCEDURES FOR QUANTITATION AND DETECTION OF VIRUS , 1959 .

[38]  T. Benjamin Chapter 5 – Polyoma Viruses , 2007 .

[39]  C. Cole Polyomaviridae : the viruses and their replication , 2001 .

[40]  B. Henderson,et al.  Spontaneous tumors and C-type virus in polyoma-infected aging wild house mice. , 1974, Journal of the National Cancer Institute.

[41]  F. Schmidt [POLYOMA VIRUS]. , 1963, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete.

[42]  W. Rowe The epidemiology of mouse polyoma virus infection. , 1961, Bacteriological reviews.